Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.
Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
Sci Rep. 2024 May 1;14(1):10008. doi: 10.1038/s41598-024-60635-0.
Historically, investigators have not differentiated between patients with and without hemorrhagic transformation (HT) in large core ischemic stroke at risk for life-threatening mass effect (LTME) from cerebral edema. Our objective was to determine whether LTME occurs faster in those with HT compared to those without. We conducted a two-center retrospective study of patients with ≥ 1/2 MCA territory infarct between 2006 and 2021. We tested the association of time-to-LTME and HT subtype (parenchymal, petechial) using Cox regression, controlling for age, mean arterial pressure, glucose, tissue plasminogen activator, mechanical thrombectomy, National Institute of Health Stroke Scale, antiplatelets, anticoagulation, temperature, and stroke side. Secondary and exploratory outcomes included mass effect-related death, all-cause death, disposition, and decompressive hemicraniectomy. Of 840 patients, 358 (42.6%) had no HT, 403 (48.0%) patients had petechial HT, and 79 (9.4%) patients had parenchymal HT. LTME occurred in 317 (37.7%) and 100 (11.9%) had mass effect-related deaths. Parenchymal (HR 8.24, 95% CI 5.46-12.42, p < 0.01) and petechial HT (HR 2.47, 95% CI 1.92-3.17, p < 0.01) were significantly associated with time-to-LTME and mass effect-related death. Understanding different risk factors and sequelae of mass effect with and without HT is critical for informed clinical decisions.
从历史上看,对于有生命威胁的大面积效应(LTME)风险的大核心缺血性卒中患者,研究者并未区分是否有出血性转化(HT)。我们的目的是确定 HT 患者与无 HT 患者相比,LTME 是否发生得更快。我们对 2006 年至 2021 年间有≥1/2 MCA 区域梗死的患者进行了一项两中心回顾性研究。我们使用 Cox 回归检验了 LTME 时间与 HT 亚型(实质、点状)之间的关联,同时控制了年龄、平均动脉压、血糖、组织型纤溶酶原激活物、机械血栓切除术、国立卫生研究院卒中量表、抗血小板药物、抗凝药物、体温和卒中侧。次要和探索性结局包括与肿块效应相关的死亡、全因死亡、处置和减压性颅骨切除术。在 840 名患者中,358 名(42.6%)无 HT,403 名(48.0%)患者有点状 HT,79 名(9.4%)患者有实质 HT。317 名(37.7%)患者发生 LTME,100 名(11.9%)患者发生与肿块效应相关的死亡。实质 HT(HR 8.24,95%CI 5.46-12.42,p<0.01)和点状 HT(HR 2.47,95%CI 1.92-3.17,p<0.01)与 LTME 时间和与肿块效应相关的死亡显著相关。了解有和无 HT 的肿块效应的不同风险因素和后果对于做出明智的临床决策至关重要。